Orange Book product · Brand (NDA)
UNIRETIC
HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
At a glance
Jun 27, 1997
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 27, 1997
29 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
Strength
12.5MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 020729
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 2014MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 202150 · HERITAGE
- 2010MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 090718 · GLENMARK PHARMS
- 2008MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 090096 · CHARTWELL RX
- 2007MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 076980 · TEVA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
